GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome – A case report, systemic review and implication for vaccine development

BACKGROUND: Guillain Barre Syndrome (GBS) and Miller Fisher Syndrome (MFS) are emerging as known consequences of COVID-19 infection. However, there have been no reported cases with positive GM1 or GQ1b antibodies in the literature to date. Although clinically similar, the pathophysiology of COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Dufour, Catherine, Co, Thien-Kim, Liu, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805391/
https://www.ncbi.nlm.nih.gov/pubmed/33462567
http://dx.doi.org/10.1016/j.bbih.2021.100203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805391/
https://www.ncbi.nlm.nih.gov/pubmed/33462567
http://dx.doi.org/10.1016/j.bbih.2021.100203

Ejemplares similares